Company Profile

Avadel Pharmaceuticals Plc (NASDAQ: AVDL)
4:00 PM EDT, 06/29/22
Last: $2.34 Change: +0.00 %Change: +0.00% Volume: 311,013
Detailed Quote
Open: $ 2.31   Volume: 311,013
High: $ 2.38   Yield(%) 0.00
Low: $ 2.26   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 138.13M
EPS ($) -1.54   Shares Out: 59.03M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 5.88
% Price Change (last 13 weeks): -66.52
% Price Change (last 26 weeks): -70.68
% Price Change (last 52 weeks): -66.43
% Price Change (year to date): -71.77
Management Effectiveness
Return on Equity (%): -64.30
Return on Assets (%): -27.67
Return on Invested Capital (%): -8.90
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $3.56
200-day Moving Average: $6.88
Avg. Daily Vol. (last 50 days): 4,857,145
Avg. Daily Vol. (last 200 days): 1,627,522
52-wk high: $11.59
52-wk low: $1.05
Bid: $2.65
Ask: $2.72
Company Information
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its products include Bloxiverz, Vazculep, Nouress, and Akovaz. It focuses on the approval of FT218, a formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was founded in 1990 and is headquartered in Dublin, Ireland.
Avadel Pharmaceuticals Plc
10 Earlsfort Terrace
Dublin DU 02

Phone: 353.1.901.5201
Fax: n/a
http://www.avadel.com
Per Share Data
Earnings (1year) ($): -1.54
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 1.32
Cash Flow ($): n/a
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 6.10
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 9.17
Current Ratio (x): 9.17
LT Debt/Equity (x): 184.18
Total Debt/Equity (x): 185.32



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.